Fulgent Genetics
FLGT
FLGT
182 hedge funds and large institutions have $350M invested in Fulgent Genetics in 2024 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 57 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.07% more ownership
Funds ownership: 51.04% → 53.11% (+2.1%)
14% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 57
Holders
182
Holding in Top 10
–
Calls
$44.4M
Puts
$314K
Top Buyers
| 1 | +$6.78M | |
| 2 | +$5.85M | |
| 3 | +$5.16M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.9M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$2.7M |
Top Sellers
| 1 | -$9.91M | |
| 2 | -$2.6M | |
| 3 | -$2.39M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.64M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$874K |